If you're interested in becoming a contributor or requesting changes then click here to join the discord

Changes

Jump to navigation Jump to search
189 bytes added ,  19:28, 7 March 2022
no edit summary
Line 1: Line 1:  
[[Category:Organizations]]
 
[[Category:Organizations]]
 
[[Category:Companies]]
 
[[Category:Companies]]
"ONWARD (formerly GTX Medical) is a medical technology company developing and commercializing innovative therapies to enable functional recovery for people with spinal cord injuries. Driven by its mission to restore movement, independence, and health, ONWARD builds on more than a decade of fundamental science and preclinical research conducted at the world’s leading neuroscience laboratories. ONWARD’s ARC Therapy, delivered by proprietary implantable or external systems, is designed to deliver targeted, programmed stimulation of the spinal cord in order to restore movement and other functions in people with spinal cord injury and improve their quality of life. Both of ONWARD’s technology platforms have been awarded Breakthrough Device Designation by the FDA. ONWARD is headquartered at the High Tech Campus in Eindhoven, the Netherlands and the EPFL Innovation Park in Lausanne, Switzerland, with a growing U.S. presence in Boston, Massachusetts, USA."
+
"ONWARD (formerly GTX Medical) is a medical technology company developing and commercializing innovative therapies to enable functional recovery for people with spinal cord injuries. Driven by its mission to restore movement, independence, and health, ONWARD builds on more than a decade of fundamental science and preclinical research conducted at the world\xe2\x80\x99s leading neuroscience laboratories. ONWARD\xe2\x80\x99s ARC Therapy, delivered by proprietary implantable or external systems, is designed to deliver targeted, programmed stimulation of the spinal cord in order to restore movement and other functions in people with spinal cord injury and improve their quality of life. Both of ONWARD\xe2\x80\x99s technology platforms have been awarded Breakthrough Device Designation by the FDA. ONWARD is headquartered at the High Tech Campus in Eindhoven, the Netherlands and the EPFL Innovation Park in Lausanne, Switzerland, with a growing U.S. presence in Boston, Massachusetts, USA."
      Line 10: Line 10:     
[[Brain Computer Interface Classification|BCI Categories]]: Open-Loop Afferent, Closed-Loop Afferent
 
[[Brain Computer Interface Classification|BCI Categories]]: Open-Loop Afferent, Closed-Loop Afferent
 +
 +
[[:Category:Neurosensing_Techniques|Neurosensing Technique(s)]]: IEEG
 +
 +
[[:Category:Neurostimulation_Techniques|Neurostimulation Technique(s)]]: Microstimulation
 
==Links==
 
==Links==
 
[https://www.onwd.com/ Website]
 
[https://www.onwd.com/ Website]
 
[https://www.crunchbase.com/organization/gtx-medical Crunchbase]
 
[https://www.crunchbase.com/organization/gtx-medical Crunchbase]
 
[https://www.linkedin.com/company/onwdempowered/ LinkedIn]
 
[https://www.linkedin.com/company/onwdempowered/ LinkedIn]

Navigation menu